Status:

TERMINATED

e-Nature VR: Evaluation of the Impact of Virtual Reality During Breast Biopsy

Lead Sponsor:

Hospital Israelita Albert Einstein

Conditions:

Pain

Breast Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Randomized clinical trial about the evaluation of the impact of the virtual reality intervention on the experience of pain, physical and psychological discomfort, well-being and anxiety of women durin...

Detailed Description

Breast biopsy is one of the main tests for the diagnosis of cancer, which generates emotional distress and can be a painful procedure. Distraction has considerable efficacy among mild psychological me...

Eligibility Criteria

Inclusion

  • Voluntary participation;
  • Signed in the Informed Consent Form;
  • Patients with clinical conditions and preserved communication function, in other words, lucid patients;
  • Patients in breast biopsy procedure.

Exclusion

  • Blind patients;
  • Patients without the capacity for judgment, in other words, with dementia;
  • Patients who have their clinical condition changed during the breast biopsy. Patients with history of nauseas vertigo and labyrinthitis

Key Trial Info

Start Date :

July 31 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 23 2022

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT03877094

Start Date

July 31 2019

End Date

April 23 2022

Last Update

May 31 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Israelita Albert Einstein

São Paulo, Brazil, 05652 900

e-Nature VR: Evaluation of the Impact of Virtual Reality During Breast Biopsy | DecenTrialz